GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+58.51%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.77B
AUM Growth
+$2.77B
(+49%)
Cap. Flow
+$30.1M
Cap. Flow
% of AUM
1.09%
Top 10 Holdings %
Top 10 Hldgs %
31.68%
Holding
209
New
25
Increased
86
Reduced
78
Closed
18
Top Buys
| 1 |
Magnite
MGNI
|
$30.3M |
| 2 |
BlackLine
BL
|
$30.2M |
| 3 |
Workiva
WK
|
$23.5M |
| 4 |
HealthEquity
HQY
|
$23.1M |
| 5 |
Axon Enterprise
AXON
|
$20.3M |
Top Sells
| 1 |
Chegg
CHGG
|
$58.8M |
| 2 |
Paycom
PAYC
|
$31.7M |
| 3 |
SPS Commerce
SPSC
|
$20.5M |
| 4 |
Paylocity
PCTY
|
$19M |
| 5 |
Etsy
ETSY
|
$18.2M |
Sector Composition
| 1 | Technology | 35.16% |
| 2 | Healthcare | 18.29% |
| 3 | Industrials | 13.17% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Communication Services | 6.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Editas Medicine
EDIT
$225M
| $2.08M | 0.08% |
70,305
+15,768
| +29% | +$467K |
|
152
Airgain
AIRG
$50.2M
| $2.06M | 0.07% |
+191,971
| New | +$2.06M |
|
153
Cidara Therapeutics
CDTX
$1.61B
| $2.06M | 0.07% |
27,911
-854
| -3% | -$63K |
|
154
Fennec Pharmaceuticals
FENC
$247M
| $2.05M | 0.07% |
245,377
-24,832
| -9% | -$207K |
|
|
SHSP
155
DELISTED
SharpSpring, Inc.
SHSP
| $1.99M | 0.07% |
226,580
+24,631
| +12% | +$216K |
|
156
Standard BioTools
LAB
$493M
| $1.9M | 0.07% |
472,970
-269,745
| -36% | -$1.08M |
|
157
Expedia Group
EXPE
$26.3B
| $1.85M | 0.07% |
+22,518
| New | +$1.85M |
|
|
RWT
158
Redwood Trust
RWT
$793M
| $1.81M | 0.07% |
258,680
-103,806
| -29% | -$727K |
|
159
Intellia Therapeutics
NTLA
$1.26B
| $1.6M | 0.06% |
76,305
+16,963
| +29% | +$357K |
|
|
SIEN
160
DELISTED
Sientra, Inc.
SIEN
| $1.43M | 0.05% |
37,057
-43,940
| -54% | -$1.7M |
|
161
Xenon Pharmaceuticals
XENE
$2.99B
| $1.39M | 0.05% |
110,999
| – | – |
|
|
AKTS
162
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $1.37M | 0.05% |
164,979
+11,616
| +8% | +$96.3K |
|
163
Organogenesis Holdings
ORGO
$629M
| $1.35M | 0.05% |
350,280
+64,290
| +22% | +$247K |
|
164
Datadog
DDOG
$46.2B
| $1.19M | 0.04% |
13,658
-14,361
| -51% | -$1.25M |
|
165
Diamondback Energy
FANG
$41.2B
| $1.13M | 0.04% |
+26,952
| New | +$1.13M |
|
166
Angi Inc
ANGI
$792M
| $1.12M | 0.04% |
+9,234
| New | +$1.12M |
|
167
Sangamo Therapeutics
SGMO
$161M
| $1.11M | 0.04% |
123,951
+22,853
| +23% | +$205K |
|
|
NBRV
168
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $933K | 0.03% |
5,533
+4,497
| +434% | +$758K |
|
169
Bio-Rad Laboratories Class A
BIO
$7.8B
| $929K | 0.03% |
+2,058
| New | +$929K |
|
|
ABMD
170
DELISTED
Abiomed Inc
ABMD
| $919K | 0.03% |
3,802
-17,836
| -82% | -$4.31M |
|
171
Tyler Technologies
TYL
$24B
| $910K | 0.03% |
+2,621
| New | +$910K |
|
172
Xeris Biopharma Holdings
XERS
$1.27B
| $905K | 0.03% |
+340,403
| New | +$905K |
|
173
Johnson Outdoors
JOUT
$405M
| $892K | 0.03% |
+9,798
| New | +$892K |
|
|
PFIE
174
DELISTED
Profire Energy, Inc
PFIE
| $860K | 0.03% |
1,027,006
-342,465
| -25% | -$287K |
|
|
SOHO
175
Sotherly Hotels
SOHO
$16.8M
| $799K | 0.03% |
317,151
-34,418
| -10% | -$86.7K |
|